Building Community Capacity to Participate in Cancer Prevention Research

von Eschenbach A.C. Keynote speech: progress with a purpose. Cancer. 2005; 104(12 suppl): 2903–2904.

Clinical Trials Working Group. Restructuring the national cancer clinical trials enterprise: report of the Clinical Trials Working Group of the National Cancer Advisory Board. June 2005. Available at: http://integratedtrials.nci.nih.gov/ict/CTWG_report_June2005.pdf. Accessed July 31, 2006.

National Institutes of Health Office of the Director. Overview of the NIH roadmap. Available at: http://nihroadmap.nih.gov/overview.asp. Accessed July 31, 2006.

President's Cancer Panel. Translating research into cancer care: delivering on the promise. June 2005. Available at: http://deainfo.nci.nih.gov/advisory/pcp/pcp04-05rpt/ReportTrans.pdf. Accessed July 31, 2006.

US Dept of Health Education and Welfare. Request for Research Grant Applications: RFA No. 10-NIH-DRCCA Community Clinical Oncology Program, National Cancer Institute. Silver Spring, Md: Division of Resources, Centers, and Community Activities, NCI; July 16, 1982.

Feigl P. , Patmont C. , Rodenbaugh J. Community Cancer Care Evaluation (CCCE) Final Report: Vol 5, Integrated Analysis. (NCI Contract No. N01-CN-35009). Seattle, Wash: Statistical Analysis and Quality Control Center, Fred Hutchinson Cancer Research Center; 1987.

Ford L. , Kaluzny A.D. , Sondik E. Diffusion and adoption of state-of-the-art therapy. Semin Oncol. 1990; 17: 485–494.

Kaluzny A.D. , Warnecke R.B. , Lacey L.M. Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program. J Natl Cancer Inst. 1993; 85: 1807–1811.

Klabunde C.N. , Kaluzny A.D. , Warnecke R.B. Bringing cancer prevention and control protocols to the community. In: Kaluzny A.D. , Warnecke R.B. , eds. Managing a Health Care Alliance: Improving Community Cancer Care. 2nd ed. Frederick, Md: Beard Books Inc; 2000: 147–170.

Weiner B.J. , McKinney M.M. , Carpenter W.R. Adapting clinical trials networks to promote cancer prevention and control research. Cancer. 2006; 106: 180–187.

Fisher B. , Costantino J.P. , Wickerham D.L. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998; 90: 1371–1388.

Thompson I.M. , Goodman P.J. , Tangen C.M. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003; 349: 215–224.

Vogel V.G. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Clin Cancer Res. 2001; 7(12 suppl): 4413s–4418s.

Wickerham D.L. Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial. Recent Results Cancer Res. 2003; 163: 87–95.

Lippman S.M. , Goodman P.J. , Klein E.A. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005; 97: 94–102.

Cook E.D. , Moody-Thomas S. , Anderson K.B. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials. 2005; 2: 436–442.

McCaskill-Stevens W. , McKinney M.M. , Whitman C.G. , Minasian L.M. Increasing minority participation in cancer clinical trials: the Minority-Based Community Clinical Oncology Program experience. J Clin Oncol. 2005; 23: 5247–5254.

Barnsley J. , Hynes D.M. , Warnecke R.B. Ensuring access to quality care. In: Kaluzny A.D. , Warnecke R.B. , eds. Managing a Health Care Alliance: Improving Community Cancer Care. 2nd ed. Frederick, Md: Beard Books Inc; 2000: 59–82.

Greenhalgh T. , Robert G. , Macfarlane F. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004; 82: 581–629.

Rogers E.M. Diffusion of Innovations. 5th ed. New York, NY: Free Press; 2003.

National Cancer Institute. Decades of progress: 1983–2003: Community Clinical Oncology Program. Available at: http://www.cancer.gov/prevention/ccop20th. Accessed July 31, 2006.